NEWS
![[Getnews] C&R Research And Rophibio Join Forces For Global Biosimilar Clinical Trials](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Getnews] C&R Research and Rophibio join forces for global biosimilar clinical trials
2022-11-21
C&R Research (CEO Moon-Tae Yoon), a contract research organization (CRO), and Rophibio (CEO Sung-Ho Hahm) conducted major national clinical trials…
[Getnews] C&R Research, 3Q sales of KRW 12.7 billion, cumulative sales of KRW 36.1 billion… highest performance
2022-11-14
C&R Research (CEO Moon-Tae Yoon), Korea's largest clinical trial consignment agency, recorded quarterly sales of KRW 12.7 billion in the…
[Bokuennews] C&R Research introduces Medidata ‘Rave CTMS’
2022-11-07
Medidata announced that C&R Research, Korea’s largest clinical trust organization (CRO), will introduce ‘Rave CTMS’ for efficient management and operation…
[MTN News] C&R Research signs MOU with Mediplexus
2022-10-17
C&R Research, Korea’s largest clinical trial consignment institution, announced on the 17th that it signed a ‘Memorandum of Understanding (MOU)…
[Itooza] C&R Research signs KRW 20.7 billion supply contract for clinical trial work
2022-10-12
C&R Research announced on the 12th that it had signed a supply contract worth KRW 20,712,060,000 for the consignment of…